Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIP: HCV Treatment in San Francisco Jail
NCT03018353Phase 4Unknown
- Sponsor
- San Francisco Department of Public Health
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C virus infection, sponsored by San Francisco Department of Public Health. Status: unknown.
02
Drugs
velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03018353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018353.